Article
Immune cell density differences in normal breast lobules of BRCA1/2 mutation carriers, women with benign breast disease and healthy research volunteers
2022-07-15
Abstract excerpt
<title>Abstract</title> <p>Purpose Breast cancer risk is elevated in pathogenic germline <italic>BRCA 1/2</italic> mutation carriers due to compromised DNA quality control and elevated mutagenic load. We hypothesized that if immunosurveillance promotes tumor suppression, then normal breast lobules from BRCA carriers may demonstrate higher immune cell densities. Methods We assessed immune cell composition in nor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 900d0d88-0103-5612-9406-ee586401adbd
- DOI
- 10.21203/rs.3.rs-1720667/v1
